martes, 13 de octubre de 2026

Many patient, consumer reps on FDA advisory panels have ties to groups funded by pharma, analysis finds Findings highlight gap in conflict-of-interest policy that could be source of undue influence

https://www.statnews.com/pharmalot/2026/10/13/many-patient-and-consumer-reps-on-fda-advisory-committees-ties-to-groups-funded-by-pharma/ By Ed SilvermanOct. 13, 2026 Pharmalot Columnist, Senior Writer

No hay comentarios: